247 related articles for article (PubMed ID: 21136029)
21. Cholangiocarcinoma and the role of radiation and chemotherapy.
Price P
Hepatogastroenterology; 2001; 48(37):51-2. PubMed ID: 11268997
[TBL] [Abstract][Full Text] [Related]
22. Management of hilar bile duct carcinoma.
Bathe OF; Pacheco JT; Ossi PB; Hamilton KL; Franceschi D; Sleeman D; Levi JU; Livingstone AS
Hepatogastroenterology; 2001; 48(41):1289-94. PubMed ID: 11677948
[TBL] [Abstract][Full Text] [Related]
23. Surgical resection after downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer: a retrospective single-center study.
Kato A; Shimizu H; Ohtsuka M; Yoshidome H; Yoshitomi H; Furukawa K; Takeuchi D; Takayashiki T; Kimura F; Miyazaki M
Ann Surg Oncol; 2013 Jan; 20(1):318-24. PubMed ID: 23149849
[TBL] [Abstract][Full Text] [Related]
24. Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis.
Yadav S; Xie H; Bin-Riaz I; Sharma P; Durani U; Goyal G; Borah B; Borad MJ; Smoot RL; Roberts LR; Go RS; McWilliams RR; Mahipal A
Eur J Surg Oncol; 2019 Aug; 45(8):1432-1438. PubMed ID: 30914290
[TBL] [Abstract][Full Text] [Related]
25. Intraluminal low-dose-rate 192Ir brachytherapy combined with external beam radiotherapy and biliary stenting for unresectable extrahepatic bile duct carcinoma.
Takamura A; Saito H; Kamada T; Hiramatsu K; Takeuchi S; Hasegawa M; Miyamoto N
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1357-65. PubMed ID: 14630274
[TBL] [Abstract][Full Text] [Related]
26. Salvage radiotherapy for locoregionally recurrent extrahepatic bile duct cancer after radical surgery.
Kim E; Kim YJ; Kim K; Song C; Kim JS; Oh DY; Nam EM; Chie EK
Br J Radiol; 2017 Dec; 90(1080):20170308. PubMed ID: 28937265
[TBL] [Abstract][Full Text] [Related]
27. External radiotherapy and brachytherapy in the management of extrahepatic and intrahepatic cholangiocarcinoma: available evidence.
Sahai P; Kumar S
Br J Radiol; 2017 Aug; 90(1076):20170061. PubMed ID: 28466653
[TBL] [Abstract][Full Text] [Related]
28. Intraluminal brachytherapy in bile duct carcinomas.
Leung J; Guiney M; Das R
Aust N Z J Surg; 1996 Feb; 66(2):74-7. PubMed ID: 8602818
[TBL] [Abstract][Full Text] [Related]
29. Impact of intraoperative radiotherapy (IORT) on survival of patients with unresectable hilar cholangiocarcinoma.
Kaiser GM; Frühauf NR; Lang H; Sauerwein W; Sotiropoulos GC; Zöpf T; Grabellus F; Wittig A; Oldhafer KJ; Malagó M; Broelsch CE
Hepatogastroenterology; 2008; 55(88):1951-4. PubMed ID: 19260456
[TBL] [Abstract][Full Text] [Related]
30. Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival.
Pitt HA; Nakeeb A; Abrams RA; Coleman J; Piantadosi S; Yeo CJ; Lillemore KD; Cameron JL
Ann Surg; 1995 Jun; 221(6):788-97; discussion 797-8. PubMed ID: 7794082
[TBL] [Abstract][Full Text] [Related]
31. Main bile duct carcinoma management. Our experience on 38 cases.
Cavallaro A; Cavallaro V; Di Vita M; Cappellani A
Ann Ital Chir; 2009; 80(2):107-11. PubMed ID: 19681291
[TBL] [Abstract][Full Text] [Related]
32. Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series.
Lunsford KE; Javle M; Heyne K; Shroff RT; Abdel-Wahab R; Gupta N; Mobley CM; Saharia A; Victor DW; Nguyen DT; Graviss EA; Kaseb AO; McFadden RS; Aloia TA; Conrad C; Li XC; Monsour HP; Gaber AO; Vauthey JN; Ghobrial RM;
Lancet Gastroenterol Hepatol; 2018 May; 3(5):337-348. PubMed ID: 29548617
[TBL] [Abstract][Full Text] [Related]
33. Intraoperative radiotherapy for unresectable cholangiocarcinoma--the Mayo Clinic experience.
Monson JR; Donohue JH; Gunderson LL; Nagorney DM; Bender CE; Wieand HS
Surg Oncol; 1992 Aug; 1(4):283-90. PubMed ID: 1341262
[TBL] [Abstract][Full Text] [Related]
34. The palliation of cholangiocarcinoma.
Shariff MI; Khan SA; Westaby D
Curr Opin Support Palliat Care; 2013 Jun; 7(2):168-74. PubMed ID: 23422512
[TBL] [Abstract][Full Text] [Related]
35. Results of treatment of extrahepatic cholangiocarcinoma at Kaunas University of Medicine Hospital.
Jievaltas M; Jasenas M; Drigotas M; Barauskas G; Pundzius J
Medicina (Kaunas); 2003; 39(2):144-50. PubMed ID: 12626867
[TBL] [Abstract][Full Text] [Related]
36. [Long-term survival of a patient with extrahepatic cholangiocarcinoma treated with adjuvant radiotherapy for positive ductal margins after surgical resection].
Yoshikawa T; Asakura Y; Higashino N; Arimoto A; Hosono M; Ueno N; Ienaga T; Hirota S; Ikura Y; Iwai Y
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1747-9. PubMed ID: 24393909
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of adjuvant radiation therapy after chemotherapy in resected extrahepatic cholangiocarcinoma: A National Cancer Database analysis.
Shridhar R; Blinn P; Huston J; Meredith KL
Cancer; 2023 Mar; 129(6):890-900. PubMed ID: 36544387
[TBL] [Abstract][Full Text] [Related]
38. Neoadjuvant therapy for cholangiocarcinoma: A comprehensive literature review.
Rizzo A; Brandi G
Cancer Treat Res Commun; 2021; 27():100354. PubMed ID: 33756174
[TBL] [Abstract][Full Text] [Related]
39. Treatment Selection and Survival Outcomes With and Without Radiation for Unresectable, Localized Intrahepatic Cholangiocarcinoma.
Jackson MW; Amini A; Jones BL; Rusthoven CG; Schefter TE; Goodman KA
Cancer J; 2016; 22(4):237-42. PubMed ID: 27441741
[TBL] [Abstract][Full Text] [Related]
40. Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer.
Skipworth JR; Olde Damink SW; Imber C; Bridgewater J; Pereira SP; Malagó M
Aliment Pharmacol Ther; 2011 Nov; 34(9):1063-78. PubMed ID: 21933219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
